Navigation Links
Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
Date:9/14/2007

p> Prepaid expenses and other current assets 1,008,464 1,453,650

Total current assets 35,387,562 32,187,286

Property and equipment, net 6,070,226 6,347,705

Restricted cash 475,000 475,000

Other assets 848,446 1,037,296

Total assets $42,781,234 $40,047,287

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Capital lease obligations and notes payable,

current portion $216,841 $86,564

Accounts payable 1,120,894 3,092,962

Accrued expenses 2,420,837 4,466,428

Accrued compensation 941,300 803,900

Deferred revenue, current portion 4,864,833 3,995,575

Total current liabilities 9,564,705 12,445,429

Capital lease obligations and notes payable,

net of current portion 275,126 229,585

Deferred rent, net of current portion 1,966,628 2,358,550

Deferred revenue, net of current portion 12,443,087 6,713,942

Total liabilities 24,249,546 21,747,506

Commitments and contingencies

Stockholders' equity:

Preferred stock of $.01 par value -

authorized 10,000,000 shares; Series A

Convertible; issued and outstanding 4,997

and 9,997 shares as of June 30, 2007 and

2006, respectively 50 100

Common stock of $.01 par value - authorized

150,000,000 shares; issued and outstanding

85,126,915 and 70,878,521 shares as of

June 30, 2007 and 2006, respectively
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...re-FirstCall/ -- BioSpecifics Technologies Corp. (...oping first-in-class collagenase-based products, t... quarter ended September 30, 2009. ,, "We were...the FDA,s Arthritis Advisory Committee unanimously...IAFLEX(TM) for the treatment of Dupuytren,s diseas...
(Date:11/6/2009)... EUCODIS Bioscience, a company,deve...enzymes for the,chemical industry announced today ... Bio Sidus, the leading biopharmaceutical company ...UCODIS Bioscience exclusive access - for the searc...ry collection of,psychrophilic bacteria strains an...
(Date:11/6/2009)...tCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ:...ced updated results from a Phase II study of intra...tatic to the lung in a poster presentation at the ...ting held in Miami Beach, Florida, from November 5...ase II Study of Intravenous REOLYSIN (Wild-type Re...
(Date:11/5/2009)... . , Fuel economy ratings for the new 2010 mod...leconomy.gov web site, which Oak Ridge National L...artment of Energy and the U.S. Environmental Prote...est fuel economy list are hybrid electrics, led by... list proves that hybrids have gone mainstream," s...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...cs,Inc. (Nasdaq: CVTX ) announced today that new ...ege of Cardiology Foundation and the American Hear...f Circulation, state that,"ranolazine may be safel..." Ranexa(R) (ranolazine extended-release tablets)...in patients who have not achieved an adequate,resp...
...tt,Limited (Nasdaq: WCRX ) announced today that i... from Barr Laboratories, Inc. ("Barr") advising th... Application (ANDA) for a,generic version of FEMCO...any during the second half,of 2006, is a chewable ...,No. 6,667,050 which expires in 2019. The Company...
...Engineering Microbes to Produce Lower Cost Anti-... TR35 2007 Recipients to be Honored at Technology...s Conference at MIT, EMERYVILLE, Calif., Aug. 15 ...t Neil Renninger, Ph.D., co-founder and senior vic... Technology Review magazine,as one of the world,s ...
Other Biology Technology:Ranexa(R) Added to New ACC/AHA Guidelines on Unstable Angina/Non ST-Elevation Myocardial Infarction (UA/NSTEMI) 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 2Warner Chilcott Announces Receipt of Paragraph IV Certification Notice 3Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Review's Prestigious TR35 List of Top Young Innovators 2Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Review's Prestigious TR35 List of Top Young Innovators 3
(Date:11/3/2009)...s greatest wines are the result of a threefold syn...ng called the "terroir" -- a term often defined as...ts will discuss terroir with an emphasis on soil s...sburgh. "Terroir: Winegrapes and the Environment"... Meetings of the American Society of Agronomy (ASA...
(Date:11/3/2009)...the ocean, cruising thousands of miles in a solita...that the sharks have maintained such a consistent ...f years the white sharks in the northeastern Pacif...on genetically distinct from sharks elsewhere in t...bile species," said Salvador Jorgensen, a postdoct...
(Date:11/3/2009)...d vegetables is a new, patented technology in whic...o label, or "etch" information on produce, thereby...ls. The technology has been licensed for use on a ... in New Zealand, Australia, and Pacific Rim countr...ca, Central and South America, Canada, and the Eur...
Breaking Biology News(10 mins):Great wines come from great soils 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Laser etching safe alternative for labeling grapefruit 2FDA Advisers Urge Smaller Doses of Acetaminophen 50458 1FDA Advisers Urge Smaller Doses of Acetaminophen 50458 2FDA Advisers Urge Smaller Doses of Acetaminophen 50458 3FDA Advisers Recommend Smaller Doses of Acetaminophen 50455 1FDA Advisers Recommend Smaller Doses of Acetaminophen 50455 2More than One Third of Docs Say Risk Level Rising for Potential H1N1 Flu Pandemic 50452 1More than One Third of Docs Say Risk Level Rising for Potential H1N1 Flu Pandemic 50452 2More than One Third of Docs Say Risk Level Rising for Potential H1N1 Flu Pandemic 50452 3
..."color-blind" method of fluorescence detection dev...e (BCM) and Rice University could open new doors t...side, the doctor,s office and even the scene of a ...direct detection of a DNA sequence from native DNA...tory, said Dr. Michael L. Metzker, assistant profe...
...molecule designed to block cat allergies successfu...e, as well as in human cells in a test tube, Unive...s report in the April issue of Nature Medicine, av...rs say, these promising results could lead to a ne...so possibly for severe food allergies such as thos...
...e crystallized form of a molecular machine that ca...ible new paths for treating diseases such as some ...plague HIV patients. , Purdue University research...re chemical complexes known as a Group I intron, a...llized introns reveal their structure and the site...
Other Biology News:Color-blind method opens new doors in DNA sequencing 2Color-blind method opens new doors in DNA sequencing 3Novel Therapy Tested in Mice Could Chase Away Cat Allergies 2Novel Therapy Tested in Mice Could Chase Away Cat Allergies 3Molecular machine may lead to new drugs to combat human diseases 2Molecular machine may lead to new drugs to combat human diseases 3
...cally collected via cardiac puncture from 3 to 4 w... is then centrifuged and frozen at -70C. The compl...led at 4C then stored at -70C. DIRECT SALES FROM P...FREEZ COMPLEMENT, YOU CAN NOW BUY DIRECTLY FROM TH...
Thermal Grayscale USB Printer for Imaging Systems; USB Connection from Alpha Innotech
GIBCO Newborn Calf Serum Heat-Inactivated from Invitrogen
Ready-To-Use IHC Bluing Reagent from Bethyl Laboratories
Biology Products: